PL404174A1 - Zastosowanie pochodnych aminowych jako inhibitorów aktywności interleukiny 15 - Google Patents
Zastosowanie pochodnych aminowych jako inhibitorów aktywności interleukiny 15Info
- Publication number
- PL404174A1 PL404174A1 PL404174A PL40417413A PL404174A1 PL 404174 A1 PL404174 A1 PL 404174A1 PL 404174 A PL404174 A PL 404174A PL 40417413 A PL40417413 A PL 40417413A PL 404174 A1 PL404174 A1 PL 404174A1
- Authority
- PL
- Poland
- Prior art keywords
- inhibitors
- amine derivatives
- interleukin activity
- interleukin
- activity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Wynalazek dotyczy zastosowania związków o wzorach ogólnych (I) lub (II) oraz ich tautomerów, izomerów, farmaceutycznie dopuszczalnych soli i solwatów, do zapobiegania i leczenia chorób, u podłoża których jest nadprodukcja interleukiny 15, takich jak reumatoidalne zapalenie stawów.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL404174A PL404174A1 (pl) | 2013-05-31 | 2013-05-31 | Zastosowanie pochodnych aminowych jako inhibitorów aktywności interleukiny 15 |
PCT/IB2014/000896 WO2014191823A1 (en) | 2013-05-31 | 2014-05-29 | Amine derivatives as il-15 activity inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL404174A PL404174A1 (pl) | 2013-05-31 | 2013-05-31 | Zastosowanie pochodnych aminowych jako inhibitorów aktywności interleukiny 15 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL404174A1 true PL404174A1 (pl) | 2014-12-08 |
Family
ID=51176400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL404174A PL404174A1 (pl) | 2013-05-31 | 2013-05-31 | Zastosowanie pochodnych aminowych jako inhibitorów aktywności interleukiny 15 |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL404174A1 (pl) |
WO (1) | WO2014191823A1 (pl) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11278505B2 (en) | 2017-04-24 | 2022-03-22 | University Of Massachusetts | Diagnosis and treatment of vitiligo |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07500580A (ja) * | 1991-09-09 | 1995-01-19 | ペプテック リミテッド | 糖尿病の合併症及び病因の処理方法 |
DE4328871A1 (de) * | 1993-08-27 | 1995-03-02 | Beiersdorf Ag | Mittel gegen empfindliche, hyperreaktive Hautzustände, atopische Dermatiden, Pruritus, Psoriasis Prurigo, Photodermatosen und Ichthyosis |
JP4989841B2 (ja) * | 2003-10-16 | 2012-08-01 | 株式会社優芳舞 | 血管新生阻害剤、血管新生を伴う疾患の治療剤または予防剤 |
CU23472A1 (es) | 2004-09-17 | 2009-12-17 | Ct Ingenieria Genetica Biotech | Péptido antagonista de la interleucina-15 |
JP2008031066A (ja) * | 2006-07-27 | 2008-02-14 | Inter Cyto Nano Science Co Ltd | 脱顆粒反応抑制剤 |
CU23716A1 (es) | 2008-09-30 | 2011-10-05 | Ct Ingenieria Genetica Biotech | Péptido antagonista de la actividad de la interleucina-15 |
-
2013
- 2013-05-31 PL PL404174A patent/PL404174A1/pl unknown
-
2014
- 2014-05-29 WO PCT/IB2014/000896 patent/WO2014191823A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014191823A1 (en) | 2014-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500195A1 (en) | Pyrimidinones as factor xia inhibitors | |
PH12018502125A1 (en) | Bipyrazole derivatives as jak inhibitors | |
MX2023004593A (es) | Inhibidores de tirosina cinasa 2 (tyk2) y usos de los mismos. | |
PH12018501151A1 (en) | Tank-binding kinase inhibitor compounds | |
PH12016502382A1 (en) | Substituted indazole compounds as irak4 inhibitors | |
PH12018500408A1 (en) | Bicyclic compounds as atx inhibitors | |
MX2018000542A (es) | Inhibidores peptidicos del receptor de interleucina 23 y su uso para tratar enfermedades inflamatorias. | |
EA201890307A1 (ru) | Индазольные и азаиндазольные соединения как ингибиторы irak-4 | |
MX2018000396A (es) | Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4). | |
EA201691302A1 (ru) | Новые гетероциклические соединения | |
MX2021003792A (es) | Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2. | |
EA201991884A2 (ru) | Ингибиторы g12c kras | |
EA201691134A1 (ru) | Новые ингибиторы глутаминазы | |
MX2018001890A (es) | Compuestos biciclicos como inhibidores de autotaxina (atx). | |
PH12018500409A1 (en) | New bicyclic compounds as dual atx/ca inhibitors | |
MX2016015565A (es) | Ciertos inhibidores de la proteina quinasa. | |
EA201990678A1 (ru) | Гетероарилкарбоксамидные соединения в качестве ингибиторов ripk2 | |
EA201790830A1 (ru) | Ингибиторы альдостеронсинтазы | |
EA201990313A1 (ru) | Производное триазолопиразинона, пригодное в качестве ингибитора фдэ1 человека | |
SG10201810263QA (en) | Nampt inhibitors and methods | |
PL404174A1 (pl) | Zastosowanie pochodnych aminowych jako inhibitorów aktywności interleukiny 15 | |
PL404138A1 (pl) | Pochodne kwasu benzoesowego jako inhibitory receptora IL-15Rα | |
PH12018500406A1 (en) | Bicyclic compounds as atx inhibitors | |
MY192305A (en) | Bipyrazole derivatives as jak inhibitors | |
EA201990686A1 (ru) | Нафтиридиновые соединения в качестве ингибиторов jak киназы |